Search results
Integrated Bio Developing Transcriptome, Methylation Screens forSmall Molecule Drug Discovery
GenomeWeb News· 12 hours agoThe firm's approach involves a proprietary multiplexing scheme that will allow it to screen hundreds of thousands of candidate molecules, creating transcriptome and methylome ...
Ancient Cauldrons Were Used For Collecting Blood, Scientists Discover
ScienceAlert via Yahoo News· 3 hours ago"Our analysis underscores the remarkable preservative properties of bronze materials, serving as...
Formosa Laboratories Completes the Acquisition of Synchem to Expand North American CDMO Footprint
Benzinga· 4 days agoTAOYUAN, June 3, 2024 /PRNewswire/ -- Formosa Laboratories, Inc., a leading API supplier and CDMO headquartered in Taiwan, has successfully completed its acquisition of SynChem, Inc., a contract research laboratory
These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts
TipRanks via Yahoo Finance· 2 days agoThere are two sides to every coin. This holds particularly true for penny stocks, or tickers that...
AI plus gene editing promises to shift biotech into high gear
The Conversation via Yahoo News· 17 hours agoAI has learned the ins and outs of proteins. Gene editing gives scientists control of life’s...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 hours agoRapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule
Short Squeeze Specialists: 3 Stocks With the Expertise to Defy Bearish Expectations
InvestorPlace· 13 hours agoFor those seeking blistering returns in a relatively short amount of time, short-squeeze stocks may...
J&J-backed Rapport Therapeutics raises $136 million in US IPO
WHTC 1450 Holland· 6 hours ago(Reuters) - Rapport Therapeutics said on Thursday that it has raised $136 million in its initial public offering in the United States at a valuation of about $601.4 million. The company said ...
Tapinarof may mark Dermavant’s first atopic dermatitis approval
Clinical Trials Arena via Yahoo Finance· 18 hours agoAccording to GlobalData’s Pharmaceutical Intelligence Centre (PIC), the pipeline landscape for AD...
Insider Selling at Zentalis Pharmaceuticals Inc (ZNTL): Presiden
Guru Focus· 6 days agoThe transaction was documented in an SEC Filing. Following this sale, the insider now owns 633,680 shares of Zentalis Pharmaceuticals Inc. Zentalis Pharmaceuticals Inc is focused on the discovery ...